Inventor

Pierre Chambon

Inventor

Blaesheim, FR

Overview

1993–2016

Patent span

Chemistry

Primary field (CPC C)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides34%

C12NMicroorganisms or enzymes23%

A61KPreparations for medical, dental or toiletry purposes13%

A01KAnimal husbandry11%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%

G01NInvestigating or analysing materials by determining their chemical or physical properties2%

PatentTitleYear

9,273,115'Method for controlling the biological activity of a protein in a vertebrate cell'2016 7,112,715'Transgenic mouse for targeted recombination mediated by modified Cre-ER'2006 7,074,611'Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof'2006 6,861,508'Transcriptional intermediary factor-2'2005 6,699,686'Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein'2004 6,653,322'Therapeutic combinations of RAR antagonists and RXR agonists and use thereof'2003 6,635,429'Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof'2003 6,521,814'Use of ligands for treatment of diseases responsive to retinoids'2003 6,486,381'Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins'2002 6,444,438'Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains'2002 6,328,956'Pharmaceutical composition for the treatment or prevention of a malignant tumor'2001 6,268,173'Polynucleotide encoding transcriptional intermediary factor-2'2001 6,203,795'Pharmaceutical composition for the treatment or prevention of a malignant tumor'2001 6,130,230'Therapeutic combinations of RAR antagonists and RXR agonists and use thereof'2000 6,093,873'Genetically engineered mice containing alterations in the gene encoding RXR'2000 6,031,149'Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins'2000 6,030,794'Genetically engineered mice and cell lines containing alterations in the genes encoding retinoic acid receptor and retinoid X receptor proteins'2000 5,922,596'Promoter of the retinoic acid receptor gene for directing gene expression'1999 5,861,381'Pharmaceutical composition for the treatment of a malignant tumor'1999 5,817,503'Method for the preparation of a protein by yeasts using an inducible system, vectors and corresponding transformed strains'1998 5,663,303'Antibodies specific for retinoic acid receptor-.gamma.'1997 5,635,596'Peptides derived from the pS2 protein'1997 5,484,726'Antibodies specific for human stromelysin-3 and a method for detection of stromelysin-3'1996 5,468,617'Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor'1995 5,376,530'Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor'1994 5,317,090'Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor'1994 5,236,844'Analytical markers for malignant breast cancer'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2016Patents assigned to CENTRE NAT RECH SCIENT (16)· patent assignee history

1993–2005Patents assigned to INST NAT SANTE RECH MED (10)· patent assignee history

1993–2005Patents assigned to UNIV PASTEUR (10)· patent assignee history

1993–2016Based in Blaesheim, FR· patent location history

1994–1995Based in Strasbourg, FR· patent location history

1996–2005Patents assigned to BRISTOL MYERS SQUIBB CO (9)· patent assignee history

1996Based in Bleasheim, FR· patent location history

1997–2000Patents assigned to SQUIBB & SONS INC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CENTRE NAT RECH SCIENT	16	1993–2016
INST NAT SANTE RECH MED	10	1993–2005
UNIV PASTEUR	10	1993–2005
BRISTOL MYERS SQUIBB CO	9	1996–2005
SQUIBB & SONS INC	3	1997–2000

Locations

Location	Patents	Span
Blaesheim, FR	23	1993–2016
Strasbourg, FR	3	1994–1995
Bleasheim, FR	1	1996